3 cm以上肾肿瘤行肾部分切除术与冷冻消融的中期肿瘤学结局:倾向性评分匹配分析
该研究比较了2006至2016年间接受肾部分切除术(PN)或冷冻消融(CA)治疗cT1/cT2、N0M0且肿瘤大于3 cm的肾肿瘤患者。经1:2倾向性评分匹配后,CA组113例、PN组57例,中位随访分别为3.8年和4.5年。CA组5年无病生存率显著低于PN组(75% vs 94%,P < .001),但两组5年无转移生存率和肿瘤特异性生存率无显著差异。
要点
- CA组5年无病生存率显著低于PN组(75% vs 94%,P < .001)。
- CA组局部复发率高于PN组(5.3% vs 1.8%),32%的CA出现技术失败。
- 两组5年无转移生存率和肿瘤特异性生存率无显著差异。
核心结论
- 对于大于3 cm的肾肿瘤,CA与较低的DFS相关,但MFS和CSS与PN相似。
研究设计与样本
- 回顾性比较研究,纳入2006至2016年间接受PN或CA治疗的cT1/cT2、N0M0且肿瘤大于3 cm的患者。
- 按年龄、BMI、Charlson合并症指数、肿瘤大小和肾脏测量评分以1:2比例进行倾向性评分匹配,CA组113例、PN组57例。
主要发现
- CA组5年DFS为75%,PN组为94%(P < .001)。
- CA组局部复发率为5.3%,PN组为1.8%。
- 32%的CA出现技术失败。
- 5年MFS:CA组100% vs PN组96%(P = .2),无显著差异。
- 5年CSS:CA组100% vs PN组98%(P = .4),无显著差异。
临床怎么用
- 作者认为,对于经过良好选择、合并症多或手术风险高的患者,CA是一种可行的选择,并可根据需要联合补救性消融。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Cryoablation (CA) and partial nephrectomy (PN) are effective nephron-sparing treatments of small renal masses. While guidelines list thermal ablation as an option for tumors < 3 cm, limited data compare PN and CA in larger tumors. We compared intermediate-term oncologic outcomes between PN and CA in renal masses > 3 cm. MATERIALS AND METHODS: Patients treated with PN or CA for cT1/cT2, N0M0 renal masses > 3 cm between 2006 and 2016 were identified. Propensity score matching was performed in a 1:2 ratio for patients undergoing CA or PN based on age, BMI, Charlson Comorbidity Index, tumor size, and nephrometry score. Disease-free survival (DFS), metastasis-free survival (MFS), cancer-specific survival (CSS), and overall survival were estimated using Kaplan-Meier analysis. RESULTS: One hundred thirteen and 57 patients underwent PN and CA with a median follow-up of 4.5 and 3.8 years, respectively. CA was associated with significantly lower 5-year DFS compared with PN (75% vs 94%, P < .001). Local recurrence was more common after CA compared with PN (5.3% vs 1.8%). Technical failure occurred with 32% of CA. However, no significant differences were observed in 5-year MFS (100% for CA vs 96% for PN, P = .2) or CSS (100% for CA vs 98% for PN, P = .4). CONCLUSIONS: CA is associated with lower DFS but similar MFS and CSS compared with PN in renal masses > 3 cm. CA is a viable option for well-selected patients with comorbidities or high surgical risk, when combined with salvage ablation as indicated.
引用
- Pickersgill NA, Vetter JM, Mittauer DJ, et al. Intermediate-Term Oncologic Outcomes of Partial Nephrectomy vs Cryoablation in Renal Tumors > 3 cm: A Propensity Score-Matched Analysis. J Urol. 2025. PMID: 40073100. doi:10.1097/JU.0000000000004524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。